PharmEasy’s ₹3,500 crore rights issue oversubscribed, co-founder Siddharth Shah to have 3-year lock-in for remaining stake

Fresh details are emerging from PharmEasy’s much sought after rights issue. The…

PharmEasy shelves IPO plans, opts for a rights issue instead

An ambitious attempt by several of India’s high profile tech unicorns to…